Profund Advisors
CLYM icon

Profund Advisors’s Climb Bio CLYM Stock Holding History

Profund Advisors’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$190K Buy
+16,555
New +$231K 0.01% 1026

Other funds holding CLYM

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Profund Advisors's CLYM Position: Q3 2026 in Review

Profund Advisors opened a new position in Climb Bio (CLYM) in Q3 2026: 16,555 shares worth $190K. The stake represents 0.01% of the portfolio and ranks #1026 among its holdings.

14 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Profund Advisors held 16,555 shares of Climb Bio worth $190K as of Q3 2026.
  • Climb Bio was a new Profund Advisors position in Q3 2026.
  • Climb Bio made up 0.01% of Profund Advisors's portfolio in Q3 2026, its #1026 holding.
  • 14 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.